PVOTF - BetterLife Pharma Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
1/30/2019
1/30/2018
1/30/2017
Total Revenue
0
0
0
0
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
183
430
87
-
Selling General and Administrative
8,425
5,128
1,041
7,639
Total Operating Expenses
9,593
6,459
1,159
7,639
Operating Income or Loss
-9,593
-6,459
-1,159
-7,639
Interest Expense
499
902
34
15
Total Other Income/Expenses Net
-369
-1,789
1,173
-482
Income Before Tax
-10,456
-9,146
-150
-8,227
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-10,456
-9,146
-150
-8,227
Net Income
-10,456
-9,146
-150
-8,227
Net Income available to common shareholders
-10,456
-9,146
-150
-8,227
Reported EPS
Basic
-
-0.10
-0.00
-0.10
Diluted
-
-0.10
-0.00
-0.10
Weighted average shares outstanding
Basic
-
90,201
79,899
75,315
Diluted
-
90,201
79,899
75,315
EBITDA
-
-7,344
-85
-8,212